Cargando…

Visuoconstructional Abilities of Patients With Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer’s Disease

BACKGROUND: Via the Vienna Visuoconstructional Test 3.0 (VVT 3.0) delayed recall we combined the assessment of visuoconstructive abilities and memory and investigated the test’s potential to support diagnostic processes, including staging and the elaboration of a cognitive profile. METHODS: We retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Knechtl, Paula, Lehrner, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265306/
https://www.ncbi.nlm.nih.gov/pubmed/36630660
http://dx.doi.org/10.1177/08919887221135549
_version_ 1785058505528442880
author Knechtl, Paula
Lehrner, Johann
author_facet Knechtl, Paula
Lehrner, Johann
author_sort Knechtl, Paula
collection PubMed
description BACKGROUND: Via the Vienna Visuoconstructional Test 3.0 (VVT 3.0) delayed recall we combined the assessment of visuoconstructive abilities and memory and investigated the test’s potential to support diagnostic processes, including staging and the elaboration of a cognitive profile. METHODS: We retrospectively analysed the data of 368 patients of the Department of Neurology, Medical University of Vienna, between 04/2014 and 10/2020 that had performed the VVT 3.0. Our sample involved 70 healthy controls (HC), 29 patients with subjective cognitive decline (SCD), 154 patients with mild cognitive impairment (MCI) and 115 patients with Alzheimer’s disease (AD). We investigated the differences in the VVT 3.0 scores, as well as the VVT’s ability to differentiate between AD and nonAD by calculating receiver-operating-characteristic (ROC) curves, ideal cut-offs and a logistic regression model. RESULTS: Results stated that the VVT 3.0 delayed recall scores were able to differentiate between all diagnostic groups, respectively, except HC-SCD and SCD-MCI. The ROC analyses determined an AUC of 0.890, 95% CI [0.855; 0.925], P < .001, and the ideal cut-off at 29.5 points that maximised sensitivity at 0.896 and specificity at 0.81. The logistic regression model classified 83.4% of AD patients correctly and delivered a significant Cohen’s Kappa of 0.619 (P < .001). CONCLUSION: As the VVT 3.0 revealed satisfactory values of diagnostic accuracy in our sample, it could enrich clinical diagnosing. However, for more clarity about its informative value in other populations, there remains a need for future studies with other samples.
format Online
Article
Text
id pubmed-10265306
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-102653062023-06-15 Visuoconstructional Abilities of Patients With Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer’s Disease Knechtl, Paula Lehrner, Johann J Geriatr Psychiatry Neurol Original Articles BACKGROUND: Via the Vienna Visuoconstructional Test 3.0 (VVT 3.0) delayed recall we combined the assessment of visuoconstructive abilities and memory and investigated the test’s potential to support diagnostic processes, including staging and the elaboration of a cognitive profile. METHODS: We retrospectively analysed the data of 368 patients of the Department of Neurology, Medical University of Vienna, between 04/2014 and 10/2020 that had performed the VVT 3.0. Our sample involved 70 healthy controls (HC), 29 patients with subjective cognitive decline (SCD), 154 patients with mild cognitive impairment (MCI) and 115 patients with Alzheimer’s disease (AD). We investigated the differences in the VVT 3.0 scores, as well as the VVT’s ability to differentiate between AD and nonAD by calculating receiver-operating-characteristic (ROC) curves, ideal cut-offs and a logistic regression model. RESULTS: Results stated that the VVT 3.0 delayed recall scores were able to differentiate between all diagnostic groups, respectively, except HC-SCD and SCD-MCI. The ROC analyses determined an AUC of 0.890, 95% CI [0.855; 0.925], P < .001, and the ideal cut-off at 29.5 points that maximised sensitivity at 0.896 and specificity at 0.81. The logistic regression model classified 83.4% of AD patients correctly and delivered a significant Cohen’s Kappa of 0.619 (P < .001). CONCLUSION: As the VVT 3.0 revealed satisfactory values of diagnostic accuracy in our sample, it could enrich clinical diagnosing. However, for more clarity about its informative value in other populations, there remains a need for future studies with other samples. SAGE Publications 2023-01-11 2023-07 /pmc/articles/PMC10265306/ /pubmed/36630660 http://dx.doi.org/10.1177/08919887221135549 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Knechtl, Paula
Lehrner, Johann
Visuoconstructional Abilities of Patients With Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer’s Disease
title Visuoconstructional Abilities of Patients With Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer’s Disease
title_full Visuoconstructional Abilities of Patients With Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer’s Disease
title_fullStr Visuoconstructional Abilities of Patients With Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer’s Disease
title_full_unstemmed Visuoconstructional Abilities of Patients With Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer’s Disease
title_short Visuoconstructional Abilities of Patients With Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer’s Disease
title_sort visuoconstructional abilities of patients with subjective cognitive decline, mild cognitive impairment and alzheimer’s disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265306/
https://www.ncbi.nlm.nih.gov/pubmed/36630660
http://dx.doi.org/10.1177/08919887221135549
work_keys_str_mv AT knechtlpaula visuoconstructionalabilitiesofpatientswithsubjectivecognitivedeclinemildcognitiveimpairmentandalzheimersdisease
AT lehrnerjohann visuoconstructionalabilitiesofpatientswithsubjectivecognitivedeclinemildcognitiveimpairmentandalzheimersdisease